Arvinas Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Elicio Therapeutics.
 Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | ||
Founding Date | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Cambridge, US HQ |
Employees | Employees 188 | Employees 22 |
Valuation ($) | Valuation ($) 294.4 m | Valuation ($) 43.9 m |
Financial | ||
Net income | Net income ($234.6m) (FY, 2023) | Net income ($35.2m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Elicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company